Envista Holdings Corp (NYSE: NVST) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $3.8B. The Maz Rating grades it against the other companies in its sector.
Envista Holdings Corp's current Maz Rating and its five factor grades are for members: log in to see them.
At $23.70, Envista Holdings Corp trades at 6.1x trailing earnings, 1.3x sales and 1.2x book value, with an EV/EBITDA of 5.0. Over the last twelve months it generated about $2.9B of revenue and $628M of net income. It runs a gross margin of 56.0%, an operating margin of 25.5% and a net margin of 22.0%. It shows return on equity of 20.5%, return on invested capital of 14.1% and a free cash flow yield of 5.9%. On the balance sheet: a debt-to-equity ratio of 0.51 and a current ratio of 2.45. Over the past 52 weeks the share price ranged from $18.77 to $30.42, with a beta of 0.94.
Envista Holdings Corp does not currently pay a dividend.
20 Wall Street analyst ratings cover the stock: 8 Buy, 11 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.